Home > Journals > Minerva Gastroenterology > Past Issues > Articles online first > Minerva Gastroenterology 2021 May 12

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Gastroenterology 2021 May 12

DOI: 10.23736/S2724-5985.21.02897-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Liver involvement in adult-onset Still’s disease: our experience in a third level liver unit and review of the literature

Michele ROMA 1, Silvia BONETTO 1, Ilaria GIOVO 1, Daniela CAMPION 1, Felice RIZZI 1, Clara L. PERONI 2, Giorgio M. SARACCO 1, Carlo ALESSANDRIA 1

1 Division of Gastroenterology and Hepatology, Città della Salute e della Scienza, Molinette Hospital, University of Turin, Turin, Italy; 2 Division of Rheumatology, Città della Salute e della Scienza, Molinette Hospital, Turin, Italy


PDF


BACKGROUND: Adult-onset Still’s Disease (AOSD) is a systemic inflammatory condition, mainly characterized by high spiking fevers, leukocytosis, skin rash, arthralgia and myalgia. Liver involvement is a frequent feature, usually presenting with hepatomegaly and mild liver enzymes abnormalities, which usually normalize after treatment with anti-inflammatory or immunomodulatory drugs given for AOSD. Although uncommon, the onset of severe acute hepatitis and even of life-threatening liver failure is possible and requires a prompt diagnosis and an aggressive therapy and, in some cases, an emergency liver transplantation. The differential diagnosis of the cause of the liver injury can be very challenging in these patients.
METHODS: We reviewed the charts of all consecutive patients admitted for acute hepatitis, between January 2019 and December 2019, to the unit of Gastroenterology and Hepatology, Molinette Hospital, Turin, Northern Italy, searching for episodes AOSD-related.
RESULTS: In this period, 21 cases of acute hepatitis were recorded with one among them diagnosed as due to AOSD. The incidence was 5% (1/21). This patient was a woman with a recent diagnosis of AOSD who developed a severe acute seronegative biopsy-proven autoimmune hepatitis. She was successfully treated with high-dose methylprednisolone, with a full and stable recovery from the liver injury.
CONCLUSIONS: We discuss the incidence, etiology, pathophysiology, diagnosis, and standard of treatment in the clinical management of AOSD with a special attention and a systematic review on the available therapies for severe liver involvement associated with AOSD.


KEY WORDS: Adult onset Still’s disease; Acute hepatitis; Liver failure

top of page